Mitigation of Radiation Pneumonopathy By Lignan Action
通过木酚素作用缓解放射性肺炎
基本信息
- 批准号:7586002
- 负责人:
- 金额:$ 100万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdverse effectsAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsApoptosisArtsCanadaCell CycleChestChinaChronicClinicClinicalClinical TrialsComplexDataDenmarkDietDietary FiberDoseEnzymesExploratory/Developmental Grant for Diagnostic Cancer ImagingExplosionExposure toFibrosisFlaxGenerationsGenesGoalsImageInjuryIonizing radiationLifeLignansLongitudinal StudiesLungLung InflammationMediatingMediator of activation proteinMethodologyModelingMusOxidative StressPathway interactionsPatientsPhasePlantsPneumoniaPositron-Emission TomographyProductionPropertyRadiationRadiation InjuriesReactive Oxygen SpeciesReperfusion InjuryRodentRoleStructure of parenchyma of lungTabletsTherapeuticTimeTissuesToxic effectTranslationsTransplantationWorkX-Ray Computed Tomographyabstractingcytotoxicdirty bombflaxseed lignanhuman TGFB1 proteininternal radiationlung injurylung ischemiamouse modelnovelnovel therapeuticspre-clinicalresponsesecoisolariciresinol diglucoside
项目摘要
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)
Oxidative Lung Damage Resulting from Repeated Exposure to Radiation and Hyperoxia Associated with Space Exploration.
与太空探索相关的反复暴露于辐射和高氧血症导致的氧化性肺损伤。
- DOI:
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Pietrofesa,RalphA;Turowski,JasonB;Arguiri,Evguenia;Milovanova,TatyanaN;Solomides,CharalambosC;Thom,StephenR;Christofidou-Solomidou,Melpo
- 通讯作者:Christofidou-Solomidou,Melpo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melpo Christofidou-Solomidou其他文献
Melpo Christofidou-Solomidou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melpo Christofidou-Solomidou', 18)}}的其他基金
NOVEL SYNTHETIC SDG TO TREAT TRAUMA-INDUCED INFLAMMATION
治疗创伤引起的炎症的新型合成 SDG
- 批准号:
8984869 - 财政年份:2015
- 资助金额:
$ 100万 - 项目类别:
NOVEL SYNTHETIC SDG TO TREAT TRAUMA-INDUCED INFLAMMATION
治疗创伤引起的炎症的新型合成 SDG
- 批准号:
8824322 - 财政年份:2015
- 资助金额:
$ 100万 - 项目类别:
Piperlongumine as a Novel Radiosensitizer for Lung Cancer
Piperlongumine 作为肺癌的新型放射增敏剂
- 批准号:
9017962 - 财政年份:2015
- 资助金额:
$ 100万 - 项目类别:
Mesothelioma inhibition by secoisolariciresinol diglucoside (SDG)
开环异落叶松树脂醇二葡萄糖苷 (SDG) 抑制间皮瘤
- 批准号:
8695307 - 财政年份:2013
- 资助金额:
$ 100万 - 项目类别:
Mesothelioma inhibition by secoisolariciresinol diglucoside (SDG)
开环异落叶松树脂醇二葡萄糖苷 (SDG) 抑制间皮瘤
- 批准号:
8598613 - 财政年份:2013
- 资助金额:
$ 100万 - 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
- 批准号:
8501743 - 财政年份:2008
- 资助金额:
$ 100万 - 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
- 批准号:
7895840 - 财政年份:2008
- 资助金额:
$ 100万 - 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
- 批准号:
7693716 - 财政年份:2008
- 资助金额:
$ 100万 - 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
- 批准号:
8103929 - 财政年份:2008
- 资助金额:
$ 100万 - 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
- 批准号:
8307407 - 财政年份:2008
- 资助金额:
$ 100万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Studentship